MEI Pharma has completed a $100 million private placement, issuing 29,239,767 common shares or prepaid warrants at $3.42 each. The funds will be allocated to establish a strategic reserve of Litecoin. Charlie Lee, Litecoin's founder and lead investor in this placement, has been appointed to MEI Pharma's board of directors. Additionally, GSR has been selected as the digital asset and fund management consultant to oversee the Litecoin reserve strategy.